Insider Stock Trading History of Chang David D


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Chang David D since year 2005. The trader's CIK number is 1611024. At the time of this reporting, Chang David D is the EVP, R&D, Chief Medical Off. of Kite Pharma, Inc. . (stock ticker symbol KITE). See this page for all insider trading activities at Kite Pharma, Inc. .


Stock purchases, sales, and option exercises reported by insider Chang David D since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-09-25 KITE Kite Pharma, Inc. Sale 7,927 179.66 1,424,196
2017-05-01 KITE Kite Pharma, Inc. Option Ex 20,000 6.89 137,800
2017-05-01 KITE Kite Pharma, Inc. Sale 20,000 82.60 1,652,000
2017-03-01 KITE Kite Pharma, Inc. Option Ex 60,000 6.89 413,400
2017-03-01 KITE Kite Pharma, Inc. Sale 60,000 79.41 4,764,600
2016-12-20 KITE Kite Pharma, Inc. Sale 1,788 50.86 90,937
2015-11-10 KITE Kite Pharma, Inc. Option Ex 30,800 6.89 212,212
2015-11-10 KITE Kite Pharma, Inc. Sale 30,800 80.02 2,464,616
2015-11-02 KITE Kite Pharma, Inc. Option Ex 7,700 6.89 53,053
2015-11-02 KITE Kite Pharma, Inc. Sale 7,700 70.11 539,870
2015-10-01 KITE Kite Pharma, Inc. Option Ex 7,700 6.89 53,053
2015-10-01 KITE Kite Pharma, Inc. Sale 7,700 55.11 424,347
2015-09-03 KITE Kite Pharma, Inc. Sale 316 55.00 17,380
2015-09-08 KITE Kite Pharma, Inc. Option Ex 7,384 6.89 50,875
2015-09-08 KITE Kite Pharma, Inc. Sale 7,384 55.00 406,120
2015-09-03 KITE Kite Pharma, Inc. Option Ex 316 6.89 2,177
2015-08-03 KITE Kite Pharma, Inc. Sale 7,700 72.56 558,712
2015-08-03 KITE Kite Pharma, Inc. Option Ex 7,700 6.89 53,053
2015-07-01 KITE Kite Pharma, Inc. Option Ex 7,700 6.89 53,053
2015-07-01 KITE Kite Pharma, Inc. Sale 7,700 62.14 478,501
2014-06-25 KITE Kite Pharma, Inc. Buy 4,000 17.00 68,000
2015-06-15 KITE Kite Pharma, Inc. Option Ex 7,700 6.89 53,053
2015-06-15 KITE Kite Pharma, Inc. Sale 7,700 56.97 438,645

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Chang David D (EVP, R&D, Chief Medical Off. of Kite Pharma, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.